Fundamental Analysis
85 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +2837.1% | +985.8% | 3 / 3 | -70.8% | +17.73 pp | +756.92 pp | +63.7% | 0.00 | 1.63 | 14,7 | −70,8% | 113 | +2.837,1% | 1.63 | -6.37 | — |
| Pts | 12 | 12 | 12 | 0 | 12 | 12 | 12 | 12 | 8 | |||||||
Valuation annotation:Price: 13.800 (close price on 2026-10-15)EPS (TTM): 8.472
Financial charts
1.Revenue & growth
VND bn14,7Q2/26
1.Revenue & growth
VND bn14,7Q2/26
2.Profit & growth
VND bn113Q2/26
3.Profit mix (Penman)
VND bn110Q2/26
4.Margins & cost structure
%20.9%Q2/26
5.Returns & cash cycle
% · days-3.2%Q2/26
6.Earnings quality & cash
VND bn-1,30Q2/26
7.Asset structure
VND bn261Q2/26
8.Funding & debt health
VND bn · times261Q2/26
9.Revenue backlog
VND bn0,02Q2/26
10.Valuation
times · %1,6×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %8.686Q2/26
Adjusted EPS growth, latest quarter
29,4× higher
Average adjusted EPS growth, 3 quarters
29,4× higher
averaged over 1 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26